Send Enquiry

CURE
Tablets
Packaging and packing Type
Blister | 10x15
MRP :
₹149.06
PTR :
₹113.57
PTS :
₹102.21
Prescription medicine Read More
Composition
Send Enquiry
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Viglim M 3/850 is a tablet from Vibcare Pharma. Every tablet carries Glimepiride 3 mg and Metformin 850 mg. It falls in the oral antidiabetic class, being a sulfonylurea combined with a biguanide, and is packed as 10x15 (Blister).
Glimepiride acts on the pancreas and encourages it to release more insulin, which brings high blood sugar down. Metformin works mainly in the liver, where it reduces the amount of glucose released into the blood, and it also helps the body respond to insulin. Because the two act by different routes, they are given together so that blood sugar levels are kept steady as part of routine diabetes care.
These tablets are used as an add-on to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Warning: glimepiride can cause severe low blood sugar (hypoglycemia), and metformin carries a risk of lactic acidosis, a build-up of lactic acid in the blood; that risk is higher with kidney impairment, liver problems, heavy alcohol intake, dehydration, low oxygen states, serious infection and scans using iodinated contrast.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
Viglim M 3/850 tablets combine glimepiride and metformin to improve blood sugar control in adults with type 2 diabetes. Main uses: improves glycemic control in adults with type 2 diabetes mellitus; used as an add-on to diet and exercise; helps keep blood sugar levels in a target range as part of daily diabetes care.
Common side effects of Viglim M 3/850 Tablet include low blood sugar (hypoglycemia); nausea; diarrhoea and stomach discomfort; dizziness; headache; weakness (asthenia). Get medical help at once if you notice severe hypoglycemia; lactic acidosis (a build-up of lactic acid in the blood, linked to metformin); haemolytic anaemia in patients with G6PD deficiency.
Each Viglim M 3/850 tablet contains Glimepiride 3 mg + Metformin 850 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Viglim M 3/850 Tablet only as your doctor advises.
The MRP of Viglim M 3/850 Tablet is ₹149.06 for a pack of 10x15 (Blister). For chemists and distributors, the PTR is ₹113.57 and the PTS is ₹102.21.
Each Viglim M 3/850 tablet contains Glimepiride 3 mg + Metformin 850 mg. It comes in a pack of 10x15 (Blister).
Glimepiride acts on the pancreas and encourages it to release more insulin, which brings high blood sugar down. Metformin works mainly in the liver, where it reduces the amount of glucose released into the blood, and it also helps the body respond to insulin. Because the two act by different routes, they are given together so that blood sugar levels are kept steady as part of routine diabetes care.
Must not be used for type 1 diabetes mellitus or diabetic ketoacidosis. Must not be used in severe kidney impairment (eGFR below 30 mL/min/1.73 m2). Must not be used in acute or chronic metabolic acidosis. Must not be used by anyone with a past allergic reaction to glimepiride, metformin, sulfonamide derivatives or any ingredient of the tablet. Check with a doctor first if you have reduced kidney or liver function, are elderly, pregnant or breastfeeding, or drink alcohol in excess.
Viglim M 3/850 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner